A Visit to Fukuda Lab at Yokohama National

I have covered the work of esteemed and prolific Japanese hair loss researcher Dr. Junji Fukuda for almost ten years. I also wrote the below two detailed posts about his findings. The second of these is very lengthy because I have kept updating it for a few years.

Make sure to also check out the Yokohama National University based Fukuda Lab’s hair research page.

Update: June 15, 2025

Yet Another Visit to Fukuda Lab

Yet again, Tokyo TV visited world renowned hair loss researcher Dr. Junji Fukuda at Yokahama National University. A Japanese reader posted a link to the full video in the comments, but it did not load for me. However, I managed to find two of the segments on YouTube. You can turn on English captions in the videos. The Japanese viewer comments underneath the first video are funny.

Update: April 18, 2024

New Junji Fukuda interview given to Tokyo Television. Someone please translate it into English if you know Japanese. Not yet on YouTube.

Junji Fukuda TV Interview
Junji Fukuda TV Interview.

February 21, 2024

A Visit to Fukuda Lab at Yokohama National

Reader “Theo” just sent me a link to a very interesting diary of a hair transplant surgeon from Japan who just visited the Fukuda Lab.

Note that while Dr. Fukuda is based at Yokohama National University, the research seems to be taking place at Kanagawa Life Innovation Center (per the above link). One of the images also mentions the Kanagawa Center for Clinical Research & Strategy (KCCR). Yokohama is the second largest city in Japan and is the capital of Kanagawa Prefecture. Check out this PDF of the regenerative medicine sector at Kanagawa Prefecture.

From this visit and summary, I learn some very interesting things. There are three distinct methods in which Dr. Fukuda is pursuing hair regeneration. I mentioned them in my past lengthy post too, but now we have more clarity.

1) Dermal Papilla Cell Transplantation

“Dermal papilla cell transplantation is about to begin in Japan.

Transplantation of dermal papilla cells (via stratified culture). I assume that the “stratified cuture” in the translation means 3D culturing. Dr. Fukuda mentions that Shiseido already conducted a clinical trial using 2D culturing. In this method, cells are are lined up on a flat surface when culturing, but it only resulted in a 5% increase in hair volume. The 3D method will likely be superior and the clinical trials are about to finally begin! It is hoped to be “put into practical use within five years”.

2) Transplantation of Hair Follicle Primordium

“I think this will take some time.”

The creation of hair follicle primordia means generating hair from scratch. i.e., hair multiplication. I previously discussed the Yokohama team’s process of achieving this via increasing and mixing epithelial cells and mesenchymal cells. These then form “hair follicle primordia“ that are transplanted to the same donor’s scalp in order to regenerate hair in thinning regions of the scalp.

Per the latest feedback from Dr. Fukuda, while this process has already been proven by them in mice, human hair is a different animal. Once the primordium tissue is transplanted to human heads, the direction and length grow haphazardly. He thinks that this will take some time.

3) Transplantation of Regenerated Hair Follicles in Vitro (Organoids)

“It will likely take more than 10 years before it can be used in humans.”

The final method is in vitro regenerated hair follicle transplantation (also called organoid). In this process, hair follicles are regenerated outside the body, lengthened by almost 100%, and then transplanted into the scalp. Per Dr. Fukuda, it will likely take more than 10 years before it can be used in humans.

Other Notes

In March 2023, Dr. Fukuda and his Yokohama team published an important hair regeneration related study. They made an improvement in the expansion of hair follicle stem cells (HFSCs) and dermal papilla cells via the use of a newly designed microwell array device.

The Fukuda Lab has even undertaken research on electric stimulation of human dermal papilla cells for hair regeneration.

So in one day we get two very unique insights and forecasts from Japan! Thanks again to “Theo” for all the stellar non-English language updates from Japan and South Korea.

Fukuda Lab Hair Research
Fukuda Lab’s hair research summary poster. Source:
Naohiro Uchida, Director of Almo Plastic Clinic Hair Transplantation.

Hyperbranched Polymer Dots for Hair Growth

In spite of writing this blog for 12 years, I am constantly surprised at the various new technologies that scientists are exploring to spur hair regrowth. The latest entails something called hyperbranched polymer dots (HPDs).

Hyperbranched Polymer Dots
Hyperbranched Polymer Dots for Hair Growth. Source: Biomedicine & Pharmacotherapy, July 2025.

Hyperbranched Polymer Dots Regenerate Hair via Wnt/β-catenin Activation

A new May 2025 study from Taiwan (that will be published in the July 2025 edition of Biomedicine & Pharmacotherapy) found that hyperbranched polymer dots enhance hair follicle regeneration. It is titled:

“Hyperbranched polymer dots enhance hair follicle regeneration via Wnt/β-catenin activation: A drug-free nanozyme-based approach to hair growth therapy.”

I have covered Wnt/β-catenin numerous times on this blog, since the regulation of this signaling pathway is responsible for hair follicle development, growth and regeneration.

According to the authors:

“Unlike prior studies that employed drug-loaded microneedle systems or metal-based nanozymes for hair regrowth, HPD operates as a drug-free, intrinsically bioactive nanozyme.”

The HPDs were applied topically to mice. The subsequent hair regrowth surpassed the efficacy of conventional minoxidil. The authors conclude that polymer dots represent a promising nanomedicine-based non-invasive approach in treating hair loss.

What are HPDs?

HPDs are a novel class of nanoparticles with hyperbranched polymer structures that incorporate both quantum dots and polymers. Unlike conventional polymeric nanoparticles, HPDs possess:

  • Intrinsic fluorescence.
  • Exceptional biocompatibility.
  • Versatile surface chemistry (enabling efficient transdermal penetration and targeted follicular delivery).
  • High water solubility.

A key positive attribute of HPDs is their potential to function as a nanozyme (an artificial nanomaterial that exhibits enzyme-like catalytic activity). Unlike traditional enzymes, nanozymes exhibit remarkable catalytic stability, resistance to environmental stressors, and enhanced bioavailability.

Nanozymes can be tailored to mimic various enzymatic activities that can: reduce oxidative stress; modulate immune responses; and creation of favorable microenvironment for tissue regeneration.

Note that some of the same authors published yet another study in May 2025 that concluded that HPDs can favorably impact wound repair and healing. They combined bioactive polymer dots with picosecond laser-induced optical breakdown (LIOB) in synergistically treating the wounds.